Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 814-283-0 | CAS number: 42220-47-3
Endpoint summary
Administrative data
Description of key information
According to an OECD 423 and GLP compliant study the median lethal dose of the test item waterfree after oral administration was found to be greater than 2000 mg/kg bw in rats.
According to an OECD 402 and GLP compliant study the median lethal dose (LD50) of the test item, waterfree after dermal application was found to be greater than 2000 mg/kg bw in male and female rats.
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- GLP and guideline study.
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- Guideline and GLP study.
Additional information
Acute oral toxicity
In an acute oral toxicity study performed according to the Acute Toxic Class Method, 2000 mg/kg of the test item, waterfree (preparations in 0.5% CMC-solution) were administered by gavage to two test groups of three fasted Wistar rats each (6 females). The following test substance-related clinical observations were recorded, clinical signs occurred within 10 days after administration:
2000 mg/kg (first test group):
- No mortality occurred
- Impaired general state in all animals
- Dyspnoea in all animals
- Piloerection in all animals
- Diarrhea in all animals
- Exsiccosis in all animals
- Cowering position in all animals
- Reduced defecation in all animals
- Non defecation in two animals
- Fur contaminated with feces in one animal
- Reduced body weight in all animals
- Chromodacryorrhea in one animal
2000 mg/kg (second test group):
- Mortality in one animal
- Impaired general state in all animals
- Poor general state in one animal
- Dyspnoea in all animals
- Piloerection in all animals
- Diarrhea in all animal
- Exsiccosis in all animals
- Cowering position in one animal
- Twitching in one animal
- Tremor in one animal
- Reduced defecation in all animals
- Macroscopic pathological findings in the animal that died:
Due to the advanced putrefaction no macroscopic pathological findings could be determined.
The body weight of the animals in the first 2000 mg/kg bw test group decreased within the first 2 or 3 days after administration. Thereafter, the body weight slightly increased until the end of the first observation week. In the second week, the body weight increased within the normal range in these animals. The body weight of the surviving animals in the second 2000 mg/kg bw test group increased within the normal range throughout the study period. There were no macroscopic pathological findings in the surviving animals sacrificed at the end of the observation period (5 females).
The acute oral LD50 was calculated to be LD50, oral, rat > 2000 mg/kg bw.
Acute dermal toxicity
In an acute dermal toxicity study (Limit Test), young adult Wistar rats (5 males and 5 females) were dermally exposed to a single dose of 2000 mg/kg bw of the test item, waterfree (as suspension in 0.5 % CMC-solution). The clipped application site (dorsal and dorso-lateral parts of the trunk, comprising at least 10% of the total body surface) was covered by semi-occlusive dressing during the 24-hour exposure period. The animals were observed for 14 days.
- No mortality occurred.
- Neither signs of systemic toxicity nor skin effects were observed
- The body weight of all animals increased within the normal range throughout the study period.
- No macroscopic pathologic abnormalities were noted in the animals examined at the end of the study (5 males and 5 females).
Accordingly, the acute dermal median lethal dose (LD50) was determined to beLD50, dermal, rat > 2000 mg/kg bw
Justification for classification or non-classification
Classification,
Labelling, and Packaging Regulation (EC) No 1272/2008
The
available experimental test data are reliable and suitable for
classification purposes under Regulation (EC) No 1272/2008. The LD50 was
greater than 2000 mg/kg bw for the oral and dermal route, respectively.
As a result the substance is not considered to be classified for acute
oral and dermal toxicity under Regulation (EC) No 1272/2008, as amended
for the tenth time in Regulation (EU) No 2017/776.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
